Abstract
With the aim to improve the specificity and to reduce the cytotoxicity of polyethylenimine (PEI), we have synthesized the conjugates of the branched PEI (25 kDa) with transferrin. The transferrin-PEI (TP) conjugates with five compositions were synthesized using periodate oxidation method and confirmed by FT-IR spectroscopy and gel permeation chromatography. The free amine contents of TP conjugates, which were able to condense and deliver DNA, increased as the amount of PEI increased. TP/DNA polyplexes were characterized by measuring gel electrophoresis, ethidium bromide fluorescence quenching, particle size and zeta potential of complexes. Complete complexation of the polyplexes was observed above the N/P ratio of 5 in TP/DNA, and above 3 in PEI/DNA, respectively. The zeta potential of the complexes decreased as the amount of transferrin in TP conjugates increased. Transfection efficiency of TP conjugates was evaluated in HeLa cell and Jurkat cell systems. Among the five compositions of TP conjugates, TP-2 system mediated a higher β-galactosidase gene expression than PEI system in Jurkat cell which was known to express elevated numbers of transferrin receptors. From the results of the cell viability based on MTT assay, TP conjugates showed lower cytotoxicity compared with the PEI system. We expect that the TP conjugate can be used efficiently as a nonviral gene delivery vector.
Similar content being viewed by others
References
Ahn, C. H., Chae, S. Y., Bae, Y. H., and Kim, S. W., Biodegradable poly (ethylenimine) for plasmid DNA delivery.J. Control. Rel., 80, 273–282 (2002).
Blessing, T., Kursa, M., Holzhauser, R., Kircheis, R., and Wagner, E., Different strategies for formation of pegylated EGF-conjugated PEI/DNA complexes for targeted gene delivery.Bioconjugate Chem., 12, 529–537 (2001).
Citores, L., Ferreras, J.M., Munoz, R., Benitez, J., Jimenez, P., and Girbes, T., Targeting cancer cells with transferrin conjugates containing the non-toxic type 2 ribosome-inactivating proteins nigrin b or ebulin 1.Cancer Letters, 184, 29–35 (2002).
Erbacher, P., Bettinger, T., Belguise-Valladier, P., Zou, S., Coll, J. L., Behr, J. P., and Remy, J. S., Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody-derivatized polyethylenimines.J. Gene Med., 1, 210–222 (1999).
Gebhart, C.L. and Kabanov, A. V., Evaluation of polyplexes as gene transfer agents.J. Control. Rel., 73, 401–416 (2001).
Godbey, W. T., Wu, K. K., and Mikos, A. G., Poly(ethylenimine) and its role in gene delivery.J. Control. Rel., 60, 149–160 (1999).
Guo, W. and Lee, R. J., Receptor-targeted gene delivery via folate-conjugated polyethylenimine.AAPS Pharmsci, 1, 1–7 (1999).
Kim, T. H., Park, I. K., Nah, J. W., Choi, Y. J., and Cho, C. S., Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier.Biomaterials, 25, 3783–3792 (2004).
Kircheis, R., Kichler, A., Wallner, G., Kursa, M., Ogris, M., Felzmann, T., Buchberger, M., and Wagner, E., Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery.Gene Ther., 4, 409–418 (1997).
Kircheis, R., Schüller, S., Brunner, S., Ogris, M., Heider, K. H., Zauner, W., and Wagner, E., Polycation-based DNA complexes for tumor-targeted gene deliveryin vivo.J. Gene Med., 1, 111–120 (1999).
Kircheis, R., Wightman, L., and Wagner, E., Design and gene delivery activity of modified polyethylenimines.Adv. Drug Deliv. Rev., 53, 341–358 (2001).
Liang, K. W., Hoffman, E. P., and Huang, L., Targeted delivery of plasmid DNA to myogenic cells via transferrin-conjugated peptide nucleic acid.Mol. Ther., 1, 236–243 (2000).
Merdan, T., Callahan, J., Petersen, H., Kunath, K., Bakowsky, U., Kopeckova, P., Kissel, T., and Kopecek, J., Pegylated polyethylenimine-Fab' antibody fragment conjugates for targeted gene delivery to human ovarian carcinoma cells.Bioconjugate Chem., 14, 989–996 (2003).
Morimoto, K., Nishikawa, M., Kawakami, S., Nakano, T., Hattori, Y., Fumoto, S., Yamashita, F., and Hashida, M., Molecular weight-dependent gene transfection activity of unmodified and galactosylated polyethylenimine on hepatoma cells and mouse liver.Mol. Ther., 7, 254–261 (2003).
Ogris, M., Steinlein, P., Kursa, M., Mechtler, K., Kircheis, R., and Wagner, E., The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells.Gene Ther., 5, 1425–1433 (1998).
Ogris, M. and Wagner, E., Tumor-targeted gene transfer with DNA polyplexes.Somatic Cell Mol. Gen., 27, 85–95 (2002).
Ogris, M., Walker, G., Blessing, T., Kircheis, R., Wolschek, M., and Wagner, E., Tumor-targeted gene therapy: strategies for the preparation of ligand-polyethylene glycol-polyethylenimine/DNA complexes.J. Control. Rel., 91, 173–181 (2003).
Oku, N., Yamazaki, Y., Matsuura, M., Sugiyama, M., Hasegawa, M., and Nango, M., A novel non-viral gene transfer system, polycation liposomes.Adv. Drug Deliv. Rev., 52, 209–218 (2001).
Petersen, H., Fechner, P. M., Fischer, D., and Kissel, T., Synthesis, characterization, and biocompatibility of polyethylenimine-graft-poly(ethylene glycol) block copolymers.Macromolecules, 35, 6867–6874 (2002).
Pouton, C. W., Biological barriers to gene transfer, In Rolland, A. (Ed.). Advanced Gene Delivery. Harwood Pub., pp. 65–102, (1999).
Remy, J. S., Abdallah, B., Zanta, M. A., Boussif, O., Behr, J. P., Demeneix, B., Gene transfer with lipospermines and polyethylenimines.Adv. Drug Deliv. Rev., 30, 85–95 (1998).
Rudolph, C., Schillinger, U., Plank, C., Gessner, A., Nicklaus, P., Muller, R. H., and Rosenecker, J., Nonviral gene delivery to the lung with copolymer-protected and transferrin-modified polyethylenimine.Biochimica et Biophysica Acta, 1573, 75–83 (2002).
Snyder, S. L. and Sobocinski, P. Z., An improved 2,4,6-trinitrobenzenesulfonic acid method for the determination of amines.Analytical Biochem., 64, 284–288 (1975).
Suh, W., Han, S. O., Yu, L., and Kim, S. W., An angiogenic, endothelial-cell-targeted polymeric gene carrier.Mol. Ther., 6, 664–672 (2002).
Wagner, E., Cotten, M., Foisner, R., and Birnstiel, M. L., Transferrin-polycation-DNA complexes: The effect of polycations on the structure of the complex and DNA delivery to cells.Proc. Natl. Acad. Sci. U.S.A., 88, 4255–4259 (1991).
Zenke, M., Steinlein, P., Wagner, E., Cotten, M., Beug, H., and Birnstiel, M. L., Receptor-mediated endocytosis of transferrin-polycation conjugates: An efficient way to introduce DNA into hematopoietic cells.Proc. Natl. Acad. Sci. U.S.A., 87, 3655–3659 (1990).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, K.M., Kim, I.S., Lee, Y.B. et al. Evaluation of transferrin-polyethylenimine conjugate for targeted gene delivery. Arch Pharm Res 28, 722–729 (2005). https://doi.org/10.1007/BF02969364
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02969364